Considering that ATP7A/B function can facilitate tumor invasiveness and resistance to chemotherapy, many lessons from disease-causing ATP7A and ATP7B mutants could be learned to activate mechanisms that promote their loss of function in tumors. Here, ATP7B is linked to neoplasm.